Prospective evaluation of autoimmune and non-autoimmune subclinical hypothyroidism in Down syndrome children.

Clicks: 405
ID: 88586
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 96 articles by views in european journal of endocrinology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
to evaluate the prevalence and natural course of autoimmune and non-autoimmune subclinical hypothyroidism (SH) in Down syndrome (DS) children and adolescents.prospective multicenter study.101 DS patients with SH (TSH 5-10 mIU/L; FT4 12-22 pmol/L), aged 2-17 years at SH diagnosis were enrolled. Annual monitoring of TSH, FT4, BMI, height, L-thyroxine dose was recorded for 5 years. Thyroid autoimmunity was tested at diagnosis and at the end of follow-up.37/101 patients displayed autoantibodies positivity (group A); the remaining 64 were classified as non-autoimmune SH (group B). Group A was characterized by higher median age at SH diagnosis and by more frequent family history of thyroid disease (6.6 vs 4.7 years, p=0.001; 32.4% vs 7.8%, p=0.001 respectively), whereas congenital heart defects were more common in group B (65.6% vs 43.2%, p=0.028). Gender, median BMI (SDS), height (SDS), FT4 and TSH were similar in both groups. At the end of follow-up: 35.1% of group A patients developed overt hypothyroidism (OH) vs 17.2% of group B (p=0.041); 31.25% of group B vs 10.8% of group A became biochemically euthyroid (p=0.02); 37.8% of group A vs 51.5% of group B still had SH condition (p=0.183). Logistic regression suggested autoimmunity (OR=3.2) and baseline TSH values (OR=1.13) as predictive factors of the evolution from SH to OH.In DS children, non-autoimmune SH showed higher prevalence and earlier onset. The risk of thyroid function deterioration over time seems to be influenced by thyroid autoimmunity and higher baseline TSH values.
Reference Key
pepe2020prospectiveeuropean Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pepe, Giorgia;Corica, Domenico;de Sanctis, Luisa;Salerno, Mariacarolina;Faienza, Maria Felicia;Tessaris, Daniele;Tuli, Gerdi;Scala, Iris;Penta, Laura;Alibrandi, Angela;Pajno, Giovanni Battista;Aversa, Tommaso;Wasniewska, Malgorzata;
Journal european journal of endocrinology
Year 2020
DOI
10.1530/EJE-19-0823
URL
Keywords
Rivaroxaban venous thromboembolism neoplasm cost-benefit analysis apixaban factor xa inhibitors

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.